122 related articles for article (PubMed ID: 8129449)
1. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period.
Weaver LT; Green MR; Nicholson K; Mills J; Heeley ME; Kuzemko JA; Austin S; Gregory GA; Dux AE; Davis JA
Arch Dis Child; 1994 Feb; 70(2):84-9. PubMed ID: 8129449
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment.
Beardsmore CS; Thompson JR; Williams A; McArdle EK; Gregory GA; Weaver LT; Simpson H
Arch Dis Child; 1994 Aug; 71(2):133-7. PubMed ID: 7944533
[TBL] [Abstract][Full Text] [Related]
3. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
Farrell PM; Kosorok MR; Laxova A; Shen G; Koscik RE; Bruns WT; Splaingard M; Mischler EH
N Engl J Med; 1997 Oct; 337(14):963-9. PubMed ID: 9395429
[TBL] [Abstract][Full Text] [Related]
4. Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life.
Leung DH; Heltshe SL; Borowitz D; Gelfond D; Kloster M; Heubi JE; Stalvey M; Ramsey BW;
JAMA Pediatr; 2017 Jun; 171(6):546-554. PubMed ID: 28437538
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic antibiotics for cystic fibrosis.
Smyth A; Walters S
Cochrane Database Syst Rev; 2000; (2):CD001912. PubMed ID: 10796836
[TBL] [Abstract][Full Text] [Related]
6. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.
Chatfield S; Owen G; Ryley HC; Williams J; Alfaham M; Goodchild MC; Weller P
Arch Dis Child; 1991 Jan; 66(1 Spec No):29-33. PubMed ID: 1996888
[TBL] [Abstract][Full Text] [Related]
7. The nasal microbiota in infants with cystic fibrosis in the first year of life: a prospective cohort study.
Mika M; Korten I; Qi W; Regamey N; Frey U; Casaulta C; Latzin P; Hilty M;
Lancet Respir Med; 2016 Aug; 4(8):627-635. PubMed ID: 27180018
[TBL] [Abstract][Full Text] [Related]
8. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
9. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history.
Green MR; Weaver LT; Heeley AF; Nicholson K; Kuzemko JA; Barton DE; McMahon R; Payne SJ; Austin S; Yates JR
Arch Dis Child; 1993 Apr; 68(4):464-7. PubMed ID: 8503667
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Ren CL; Desai H; Platt M; Dixon M
Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
Smyth AR; Walters S
Cochrane Database Syst Rev; 2012 Dec; 12():CD001912. PubMed ID: 23235585
[TBL] [Abstract][Full Text] [Related]
14. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program.
Waters DL; Dorney SF; Gaskin KJ; Gruca MA; O'Halloran M; Wilcken B
N Engl J Med; 1990 Feb; 322(5):303-8. PubMed ID: 2296272
[TBL] [Abstract][Full Text] [Related]
16. Protein binding of flucloxacillin in neonates.
Pullen J; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
Ther Drug Monit; 2007 Jun; 29(3):279-83. PubMed ID: 17529883
[TBL] [Abstract][Full Text] [Related]
17. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.
Ranieri E; Ryall RG; Morris CP; Nelson PV; Carey WF; Pollard AC; Robertson EF
BMJ; 1991 May; 302(6787):1237-40. PubMed ID: 2043846
[TBL] [Abstract][Full Text] [Related]
18. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.
Sontag MK; Corey M; Hokanson JE; Marshall JA; Sommer SS; Zerbe GO; Accurso FJ
J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337
[TBL] [Abstract][Full Text] [Related]
19. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).
Siret D; Bretaudeau G; Branger B; Dabadie A; Dagorne M; David V; de Braekeleer M; Moisan-Petit V; Picherot G; Rault G; Storni V; Roussey M
Pediatr Pulmonol; 2003 May; 35(5):342-9. PubMed ID: 12687590
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
